Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1199 | Clinical Cases–Pituitary/Adrenal | ECE2015

Spontaneous resolution of bilateral avascular necrosis of the femoral head following cure of Cushing's syndrome secondary to primary pigmented micronodular adrenal disease

Pazderska Agnieszka , Crowther Stephen , Govender Pradeep , Conlon Kevin C , Gibney James , Sherlock Mark

Avascular necrosis is a rare presenting feature of endogenous hypercortisolism. The literature suggests that, if left untreated, complete collapse of the femoral head may ensue, necessitating hip replacement in up to 70% of patients. The majority of described patients with avascular necrosis due to endogenous hypercortisolaemia were treated surgically.Case report: A 36-year-old female, investigated for right leg pain, reported rapid weight gain, easy bru...

ea0034oc3.4 | Steroids | SFEBES2014

Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status

Hassan-Smith Zaki , Morgan Stuart , Sherlock Mark , Hughes Beverly , Lavery Gareth , Tomlinson Jeremy , Stewart Paul

Introduction: There is growing evidence that 11β-HSD1 expression/activity increases with age in key target tissues including adipose tissue, bone, and skin, implicating local amplification of glucocorticoids in the pathophysiology of related disease. We have previously shown that 11β-HSD1KO mice are protected from both the adverse metabolic effects of excess glucocorticoids and age-associated muscle weakness. We investigated changes in global activity and skeletal mu...

ea0031p286 | Pituitary | SFEBES2013

Growth of a meningioma in a female patient with uncontrolled congenital adrenal hyperplasia

O'Shea Triona , Crowley Rachel , Farrell Michael , Hunter Steven , Gibney James , Sherlock Mark

Context: Growth of meningiomas has been previously described in patients receiving oestrogen/progestogen therapy.Methods: Case history, laboratory findings, imaging and histology are discussed.Case history: A 45-year-old woman with a known history of 21-hydroxyase deficiency (of the non-salt wasting variety) and long-standing non-adherence with corticosteroid therapy presented to the Endocrine Clinic for follow-up care. She complai...

ea0028oc4.2 | Steroid | SFEBES2012

Age-dependent increase in the expression/activity of 11β-HSD1 in key metabolic tissues may underpin the ageing phenotype notably sarcopenia

Morgan Stuart , Sherlock Mark , Lavery Gareth , Hassan-Smith Zaki , Abrahams Lianne , Stewart Paul

The pathophysiological effects of glucocorticoid (GC) excess (Cushing’s syndrome) are similar to the aging phenotype. As such, we hypothesise that age-related changed in body composition (central obesity, reduced bone density, reduced muscle mass and skin thinning), and resultant chronic disease (type 2 diabetes, osteoporosis, sarcopenia and heart disease) may be caused by increased GC exposure with age. However, circulating GC’s show little change with advancing age...

ea0028p48 | Clinical practice/governance and case reports | SFEBES2012

A comparative quality assessment of evidence-based clinical guidelines in Endocrinology

Hazlehurst Jonathan , Armstrong Matthew , Sherlock Mark , O'Reilly Mick , Rowe Ian , Franklyn Jayne , Stewart Paul , Tomlinson Jeremy

Evidence-based clinical guidelines in Endocrinology attempt to improve and standardise patient care. There has been an expansion in guideline production although some of the heterogeneous methods used to assess the underlying evidence base may limit interpretation and implementation. Current and archived guidelines from The American Association of Clinical Endocrinologists (AACE), The Endocrine Society (ES), The American Thyroid Association, The British Thyroid Association and...

ea0025p229 | Pituitary | SFEBES2011

20 year experience in the surgical management of cushing’s disease in a UK tertiary referral centre

Hassan-Smith Zaki , Johnson Alan , Toogood Andrew , Arlt Wiebke , Sherlock Mark , Stewart Paul

Objective: The past 2 decades have seen advances in the surgical management of Cushing’s disease (CD). Our aim was to meet the need for current data on clinical features, long-term outcomes, and prognostic indicators.Patients and methods: We conducted a retrospective study of 71 patients treated by trans-sphenoidal surgery (TSS) for CD. All patients were operated on by the same surgeon in a single centre between 1988–2009. Diagnosis was confirm...

ea0019p243 | Pituitary | SFEBES2009

Growth hormone deficiency in adults: the NICE criteria do not discriminate an adverse cardiovascular phenotype

Aragon Alonso Aurora , Sherlock Mark , McGregor Elizabeth , Murray Robert , Stewart Paul M , Toogood Andrew A

Severe growth hormone (GH) deficiency in adults is associated with adverse changes in quality of life (QoL), body composition and cardiovascular risk profile. NICE guidance restricts GH replacement in the UK to those with impaired QoL, defined by a score of >11 in the QoL-AGHDA questionnaire.Aims: To assess whether the NICE guidance differentiates other clinical or biochemical features in GH deficient adults.Patients and...

ea0015p272 | Pituitary | SFEBES2008

Radiation-induced hypothalamic–pituitary damage in long term survivors of primary brain tumours is reflected by endocrine dysfunction and impaired health-related quality of life

Hammer Fabian , Sherlock Mark , Veit Stefanie , Badent Bettina , Allolio Bruno , Leussink Verena , Arlt Wiebke

Cranial radiotherapy is widely used in combination with chemotherapy to treat patients with primary brain tumours. Increased survival has lead to the recognition of long term sequelae, including endocrine dysfunction due to radiation-induced hypothalamic–pituitary damage. Here we assessed health-related quality of life and endocrine function in 31 adult long term survivors (median age 45, range 29–65 years; 21M, 10F) of primary brain tumours outside the hypothalamic&...

ea0013oc21 | Novartis Basic Endocrinology Award | SFEBES2007

Muscle cell differentiation is regulated by glucocorticoids, a process which is potentiated through the induction of 11 beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1)

Sherlock Mark , Lavery Gareth , Horsburgh Jenny , Slabbert Ana , Toogood Andy , Stewart Paul

In vivo the 11β-HSD1 enzyme converts inactive cortisone to the active glucocorticoid cortisol. 11β-HSD1 is implicated in the metabolic syndrome through its expression in liver and adipose tissue by increasing local cortisol concentrations. However, little is known regarding the expression and function of 11β-HSD1 in muscle.Murine C2C12 muscle cells (myocytes) were differentiated from myoblasts to myotubules for 8 days, with and without the...

ea0091wd14 | Workshop D: Disorders of the adrenal gland | SFEEU2023

Life-threatening hypokalaemia heralding the diagnosis of metastatic Adrenocortical Cancer (ACC) with 11-deoxycorticosterone hypersecretion

McDonnell Tara , Leanne Cussen , Miller Clare , Moran Carla , Dugal Neil , Sherlock Mark , O'Reilly Michael

A 51 year old presented with headaches, fatigue and generalised weakness. She had a background history of hypertension diagnosed one year prior to presentation. Initial laboratory evaluation demonstrated life-threatening hypokalaemia, potassium 0.9mmol/l(R.I. 3.5-5.3). This profound hypokalaemia required ICU admission for replacement of potassium and monitoring. Management of subsequent fluid overload necessitated a brief period of hemofiltration. During the course of evaluati...